IL-6 has attracted considerable interest within the context of Parkinson’s disease (PD), a progressive neurodegenerative disorder characterized by motor manifestations such as tremors, rigidity, and bradykinesia, coupled with non-motor symptoms encompassing cognitive decline and mood disturbances (80, 101–105). The gene discussed is IL6; the disease is Parkinson disease.